SUNNYVALE, California, January 28 /PRNewswire/ --

- Multi-media technology powering Europe's largest interactive retail signage system to be showcased at Amsterdam's upcoming ISE show

GestureTek Inc. -- inventor and world leader in gesture-controlled interactive entertainment and presentation systems -- announced the launch of the company's ScreenFX interactive multi-media display system in the new Charleston Mall in Dublin, Ireland. The installation is one of Europe's largest interactive retail signage systems.

GestureTek will showcase ScreenFX, and other innovations in multi-touch interactivity and immersive media, for the first time ever at a conference outside of North America at the Integrated Systems Europe (ISE) show Jan 29th to 31st in Amsterdam.

LONDON, January 28 /PRNewswire/ --

- Recognized for game-changing strategies in advertising, marketing and promotion

Real Time Content (RTC), a leader in Adaptive Media, today announced that it was chosen by AlwaysOn as one of the OnMedia 100 Winners. Inclusion in the OnMedia 100 signifies major developments in the creation of marketing tools, services, venues, advertising, branding, and public relation campaigns. RTC was specially selected by the AlwaysOn editorial team and other industry experts, based on a set of five criteria: innovation, market potential, commercialization, stakeholder value and media buzz.

JAKARTA, Indonesia, January 28 /PRNewswire/ --

Terasol LABS (www.terasollabs.com), a leading plant biotechnology company focused on the development of Jatropha curcas, Castor and other biodiesel crops, announced its program to increase feedstock production for biodiesel companies through improved Jatropha cultivation, harvesting and purchasing at the JatrophaWorld 2008 conference in Jakarta.

PARIS, January 28 /PRNewswire/ -- Sanofi-aventis announced today that the anticoagulant Clexane(R) (enoxaparin sodium injection) has been approved for marketing in Japan by the Ministry of Health, Labour and Welfare for the prevention of venous thromboembolism (VTE) in patients undergoing orthopaedic surgery of the lower limbs such as total hip replacement, total knee replacement and hip fracture surgery.

NEW YORK, January 28 /PRNewswire/ --

The Medefield Group, the number one provider of global online services to medical market research, consulting and communications companies, is pleased to announce new leadership for its North America business unit. After another year of unprecedented growth attributed to Medefield's unrivalled global physician panel, outstanding customer service, and expanding client base, the company is adding to its ever-growing team.

CANNES, France, January 28 /PRNewswire/ --

- Premier UK-Based Record Label Group Chooses RoyaltyShare Digital Sale Management Service in Combination With Musicalc

CANNES, France, January 28 /PRNewswire/ --

- Combination of Content Management and Royalty Services Deliver End-to-End Support for the Digital Music Sales Cycle

AMSTERDAM, The Netherlands, January 28 /PRNewswire/ --

- European Patent Office Grants Patent for Treatment of Non-Alcoholic Steatotic Hepatitis

AMT (Euronext: AMT), a leader in the field of human gene therapy, today announced that the European Patent Office (EPO) has granted the company an important patent for the treatment of Non-Alcoholic Steatotic Hepatitis (NASH) with its lead product AMT-11. AMT has a similar patent pending with the U.S. Patent and Trademark Office.

NEW YORK, January 28 /PRNewswire/ --

- Landmark Worldwide Survey of Leading Plastic Surgeons

- Jolie, Kidman, Anderson, Loren, Bundchen, Pitt, and Clooney Favored

We hear it every day, "Oh, I wish I could look like Angelina." Or, "Oh, to have Brad's abs -- I'd do anything." With increasing availability of aesthetic plastic surgery, ongoing improvement and refinements in procedures, and numerous payment plans available, some of these wishes are coming true. But do the celebrity images that overwhelm popular media have any influence on the decisions people make about their plastic surgery?

According to two studies published in Cell Transplantation, stroke victims may benefit from human mesenchymal stem cell (hMSC) or bone marrow stromal cell (BMSCs) transplantation. In both studies, the migration of chemically “tagged” transplanted stem cells were tracked to determine the degree to which the transplanted cells reached damaged areas of the brain and became therapeutically active.

“Both studies lend important support to a growing body of laboratory evidence that bone marrow is a remarkable adult stem cell source for transplant therapy following stroke,” says Cell Transplantation associate editor Cesar V. Borlongan, Ph.D. of the Medical College of Georgia. “The non-invasive MRI visualization of pre-labeled BMSCs could become a routine clinical marker for transplanted cells as well as for safety and efficacy.”